podophyllotoxin has been researched along with Leukemia, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernabei, P; Chiarle, R; Conti, L; Giovarelli, M; Longo, A; Novelli, F; Regis, G | 1 |
| Beck, WT; Danks, MK; Schmidt, CA; Wolverton, JS | 1 |
2 other study(ies) available for podophyllotoxin and Leukemia, T-Cell
| Article | Year |
|---|---|
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth.
Topics: Animals; Apoptosis; Cell Line, Tumor; Down-Regulation; Female; Humans; Insulin-Like Growth Factor I; Interferon-gamma; Leukemia, T-Cell; Mice; Podophyllotoxin; Receptor, IGF Type 1; Receptors, Interferon; Sensitivity and Specificity; Signal Transduction; STAT1 Transcription Factor | 2007 |
Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
Topics: Culture Media; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Humans; Hybrid Cells; Leukemia, T-Cell; Phenotype; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1989 |